pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
M-701
Wuhan YZY Biopharma Co Ltd
1 catalysts
MK-6050
$MRKMerck & Co., Inc.
1 catalysts
MK-8748
Eyebiotech Ltd
1 catalysts
MKK-900
MAXVAX Biotechnology Co Ltd
1 catalysts
MT-026
Jiangsu Maoxing Technology Co Ltd
1 catalysts
← prev
page 4 of 231
next →
131
Pain89
Neurology1
Phase 2
ONO-4578
Metastatic Colorectal Cancer
Bristol-Myers Squibb Co
1 catalysts
ORX-750
Celerion Inc
1 catalysts
PEP-CMV
National Cancer Institute US
1 catalysts
PST-611
Ilife Consulting Sarl
1 catalysts
QLS-5212
Qilu Pharmaceutical Co Ltd
1 catalysts
RC-288
RemeGen Co Ltd
1 catalysts
RPG-102
$RANIRani Therapeutics Holdings, Inc.
1 catalysts
SIBPA-13
Shanghai Institute of Biological Products Co Ltd
1 catalysts
SKB-103
Sichuan Kelun Pharmaceutical Co Ltd
1 catalysts
SSJG-009
Sunstar Inc
1 catalysts
SynPro-15G
National Cheng-Kung University Hospital
1 catalysts
UA-021
Usynova Pharmaceuticals Ltd
1 catalysts
VC-005
Jiangsu Vcare PharmaTech Co Ltd
1 catalysts
VX-993
$VERXVertex, Inc.
1 catalysts
Vacucis
Instituto de Investigacion sanitaria de Santiago de Compostela
1 catalysts
XC-243
Pharmenterprises
1 catalysts
XS-411
Beijing Tiantan Hospital
1 catalysts
ZE-740282
Avance Clinical Pty Ltd
1 catalysts
afamelanotide
Centre International de Développement Pharmaceutique
1 catalysts
alfentanil
Taian City Central Hospital
1 catalysts
Marketed
apixaban ODT
Eliquis (apixaban)
Venous Thromboembolism
Bristol-Myers Squibb Co
1 catalysts
aumolertinib mesylate
Guangzhou Panyu Central Hospital
1 catalysts
autologous platelet rich plasma
Affiliated Stomatological Hospital of Guangxi Medical University
1 catalysts
autologous regulatory T cells
Guy's and St Thomas' NHS Foundation Trust
1 catalysts
Marketed
avelumab
Bavencio (avelumab)
Merkel Cell Carcinoma
EMD Serono Inc
1 catalysts